Cloud computing is transforming biotech by offering purpose-built infrastructure that supports AI-driven drug discovery and development while meeting strict regulatory requirements. Dr. Ilya Burkov explains how Nebius provides full-stack solutions that democratize access to powerful technology, enabling researchers to achieve breakthroughs that previously required generations.
• Cloud computing market was built for general purpose workloads but biotech needs specialized infrastructure for sensitive data and AI models
• GPUs enable parallel processing that accelerates AI applications—like "a whole classroom solving math problems at once" versus CPUs solving one at a time
• Applications include drug discovery, genomics, protein structure modeling, quantum chemistry, and single-cell modeling for cancer treatment
• Nebius provides full-stack solutions with hardware and software layers, working with NVIDIA to offer specialized packages
• Democratizing access to AI infrastructure is leveling the playing field between small biotechs and large pharmaceutical companies
• Scientists can now accomplish in their lifetime what previously would have taken multiple generations of researchers
• Breaking down silos between data teams and institutions is crucial for accelerating healthcare innovation
________
Reach out to Ivanna Rosendal
Join the conversation on our LinkedIn page
